CCP’s Earnings Have Compounded at 18% Per Annum
marcellus.in · 2025-02-18 · tier T2
Source: Memo · marcellus.in dated 2025-02-18. Auto-generated factual summary. Not investment advice. Verify before acting.
Marcellus contends that in a low-churn, concentrated portfolio, earnings growth is the dominant long-run performance driver — not P/E multiple expansion, which mean-reverts over time. The firm's CCP portfolio delivered a 17.8% EPS CAGR over FY19-24, closely matching its 17.4% pre-fee return over the same period, which the firm presents as validation of the earnings-first framework. Marcellus acknowledged two missed opportunities. First, it identified the shift toward "enterprising compounders" — companies entering new industries while growing their core — 12-18 months later than it could have, which held back EPS growth in the 2019 and 2020 cohorts to roughly 11-13%. Second, it noted that trimming Dr. Lal Pathlabs, Asian Paints, and Bajaj Finance by half in early 2022 would have reduced a 14% NAV drawdown to 10-11% and added 80-100 basis points to since-inception gross returns. On the broader market, Marcellus argued that Nifty50's 24.3% EPS CAGR over FY21-24 — fuelled by commodities and government capex — is unlikely to persist, given India's nominal GDP growth of 10-12%. The firm said it will continue to avoid sectors outside its quality criteria regardless of benchmark weight. CCP returned 15.35% net of fees and expenses since FY19.
Citations · 6
“FY19-24 EPS CAGR of 17.8% is similar to the portfolio performance (pre-fees and expenses) of 17.4%”
p#10 · confidence 97%
“had we left the 2019 or 2020 Cohorts unchanged, the subsequent EPS CAGR of the portfolio constituents would have been around 11%-13%”
p#11 · confidence 96%
“added 80-100bps to the CCP's since-inception gross returns”
p#17 · confidence 95%
“after delivering an EPS CAGR of 24.3% over FY21-24, we expect mean reversion for the Nifty50's EPS growth in future”
p#24 · confidence 95%
“P/E multiple change, is a more meaningful contributor over the short term but a relatively small contributor over the longer term (because in the long term P/E multiples mean revert)”
p#4 · confidence 97%
“Marcellus CCP's five-year portfolio performance CAGR until 31st March 2024 was 15.35% net of fees and expenses”
p#10 · confidence 97%
Follow this investor
Saurabh Mukherjea
Marcellus · Indian quality compounders
More from Saurabh Mukherjea
Browse all →- Memo
Marcellus shifted CCP away from IT services and consumption toward export manufacturing, healthcare, and quality compounders to hedge AI disruption and domestic growth risks.
Sources & details
PublishedApr 16, 2026
- Memo
Summarized by DailySharpe AI